{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:16:22Z","timestamp":1790727382882,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/bjc.2011.483","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T13:39:45Z","timestamp":1323351585000},"page":"S42-S48","source":"Crossref","is-referenced-by-count":33,"title":["10. Cancers attributable to exposure to hormones in the UK in 2010"],"prefix":"10.1038","volume":"105","author":[{"given":"D M","family":"Parkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,6]]},"reference":[{"key":"BFbjc2011483_CR1","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1093\/aje\/kwq300","volume":"172","author":"NE Allen","year":"2010","unstructured":"Allen NE, Tsilidis KK, Key TJ, Dossus L, Kaaks R, Lund E, Bakken K, Gavrilyuk O, Overvad K, Tj\u00f8nneland A, Olsen A, Fournier A, Fabre A, Clavel-Chapelon F, Chabbert-Buffet N, Sacerdote C, Krogh V, Bendinelli B, Tumino R, Panico S, Bergmann M, Schuetze M, van Duijnhoven FJ, Bas Bueno-de-Mesquita H, Charlotte Onland-Moret N, van Gils CH, Amiano P, Barricarte A, Chirlaque MD, Molina-Montes ME, Redondo ML, Duell EJ, Khaw KT, Wareham N, Rinaldi S, Fedirko V, Mouw T, Michaud DS, Riboli E ( 2010 ) Menopausal hormone therapy and risk of endometrial carcinoma among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition . Am J Epidemiol 172 : 1394 \u2013 1403","journal-title":"Am J Epidemiol"},{"key":"BFbjc2011483_CR2","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ijc.25314","volume":"128","author":"K Bakken","year":"2011","unstructured":"Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, Fabre A, H\u00e9mon B, Rinaldi S, Chajes V, Slimani N, Allen NE, Reeves GK, Bingham S, Khaw KT, Olsen A, Tj\u00f8nneland A, Rodriguez L, S\u00e1nchez MJ, Etxezarreta PA, Ardanaz E, Tormo MJ, Peeters PH, van Gils CH, Steffen A, Schulz M, Chang-Claude J, Kaaks R, Tumino R, Gallo V, Norat T, Riboli E, Panico S, Masala G, Gonz\u00e1lez CA, Berrino F ( 2011 ) Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition . Int J Cancer 128 : 144 \u2013 156","journal-title":"Int J Cancer"},{"key":"BFbjc2011483_CR3","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/S0140-6736(05)66455-0","volume":"365","author":"V Beral","year":"2005","unstructured":"Beral V, Bull D, Reeves G ( 2005 ) Endometrial cancer and hormone-replacement therapy in the Million Women Study . Lancet 365 : 1543 \u2013 1551","journal-title":"Lancet"},{"key":"BFbjc2011483_CR4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","volume":"362","author":"V Beral","year":"2003","unstructured":"Beral V ( 2003 ) Breast cancer and hormone-replacement therapy in the Million Women Study . Lancet 362 : 419 \u2013 427","journal-title":"Lancet"},{"key":"BFbjc2011483_CR5","first-page":"332","volume":"15","author":"MF Chan","year":"2008","unstructured":"Chan MF, Dowsett M, Folkerd E, Wareham N, Luben R, Welch A, Bingham S, Khaw KT ( 2008 ) Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women . Menopause 15 : 332 \u2013 339","journal-title":"Menopause"},{"key":"BFbjc2011483_CR6","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","volume":"289","author":"RT Chlebowski","year":"2003","unstructured":"Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovich H, McTiernan A ( 2003 ) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative randomised trial . JAMA 289 : 3243 \u2013 3253","journal-title":"JAMA"},{"key":"BFbjc2011483_CR7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","volume":"371","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer","year":"2008","unstructured":"Collaborative Group on Epidemiological Studies of Ovarian Cancer ( 2008 ) Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls . Lancet 371 : 303 \u2013 314","journal-title":"Lancet"},{"key":"BFbjc2011483_CR8","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","volume":"347","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1996","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer ( 1996 ) Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies . Lancet 347 : 1713 \u2013 1727","journal-title":"Lancet"},{"key":"BFbjc2011483_CR9","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer ( 1997 ) Breast cancer and hormone replacement therapy collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer . Lancet 350 : 1047 \u2013 1059","journal-title":"Lancet"},{"key":"BFbjc2011483_CR10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ijc.25050","volume":"127","author":"L Dossus","year":"2010","unstructured":"Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Fournier A, Chabbert-Buffet N, Boeing H, Sch\u00fctze M, Trichopoulou A, Trichopoulos D, Lagiou P, Palli D, Krogh V, Tumino R, Vineis P, Mattiello A, Bueno-de-Mesquita HB, Onland-Moret NC, Peeters PH, Dumeaux V, Redondo ML, Duell E, Sanchez-Cantalejo E, Arriola L, Chirlaque MD, Ardanaz E, Manjer J, Borgquist S, Lukanova A, Lundin E, Khaw KT, Wareham N, Key T, Chajes V, Rinaldi S, Slimani N, Mouw T, Gallo V, Riboli E ( 2010 ) Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition . Int J Cancer 127 : 442 \u2013 451","journal-title":"Int J Cancer"},{"key":"BFbjc2011483_CR11","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1002\/ijc.25515","volume":"127","author":"JS Hildebrand","year":"2010","unstructured":"Hildebrand JS, Gapstur SM, Feigelson HS, Teras LR, Thun MJ, ;Patel AV ( 2010 ) Postmenopausal hormone use and incident ovarian cancer: associations differ by regimen . Int J Cancer 127 : 2928 \u2013 2935","journal-title":"Int J Cancer"},{"key":"BFbjc2011483_CR12","unstructured":"International Agency for Research on Cancer (IARC) ( 2007 ) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 91. Combined Estrogen-Progestogen Contraceptives and Combined Estrogen-Progestogen Menopausal Therapy . IARC: Lyon"},{"key":"BFbjc2011483_CR13","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0140-6736(07)61684-5","volume":"370","author":"P Appleby","year":"2007","unstructured":"International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de Gonz\u00e1lez A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M, Sweetland S ( 2007 ) Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies . Lancet 370 : 1609 \u2013 1621","journal-title":"Lancet"},{"key":"BFbjc2011483_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/bjc.1988.44","volume":"57","author":"TJ Key","year":"1988","unstructured":"Key TJ, Pike MC ( 1988 ) The dose-effect relationship between \u2018unopposed\u2019 oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk . Br J Cancer 57 : 205 \u2013 212","journal-title":"Br J Cancer"},{"key":"BFbjc2011483_CR15","volume-title":"Contraception and Sexual Health 2006\/07","author":"D Lader","year":"2007","unstructured":"Lader D ( 2007 ) Contraception and Sexual Health 2006\/07 . Omnibus Survey Report No. 33. Office of National Statistics . www.ons.gov.uk\/ons\/rel\/lifestyles\/contraception-and-sexual-health\/2006-07\/2006-07.pdf"},{"key":"BFbjc2011483_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.jhep.2007.03.015","volume":"47","author":"S Maheshwari","year":"2007","unstructured":"Maheshwari S, Sarraj A, Kramer J, El-Serag HB ( 2007 ) Oral contraception and the risk of hepatocellular carcinoma . J Hepatol 47 : 506 \u2013 513","journal-title":"J Hepatol"},{"key":"BFbjc2011483_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/bcr16","volume":"1","author":"Million Women Study Collaborative Group","year":"1999","unstructured":"Million Women Study Collaborative Group ( 1999 ) The Million Women Study: design and characteristics of the study population . Breast Cancer Res 1 : 73 \u2013 80","journal-title":"Breast Cancer Res"},{"key":"BFbjc2011483_CR18","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/S0140-6736(07)60534-0","volume":"369","author":"D Bull","year":"2007","unstructured":"Million Women Study Collaborators, Bull D, Green J, Reeves G ( 2007 ) Ovarian cancer and hormone replacement therapy in the Million Women Study . Lancet 369 : 1703 \u2013 1710","journal-title":"Lancet"},{"key":"BFbjc2011483_CR19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/cncr.23956","volume":"115","author":"CL Pearce","year":"2009","unstructured":"Pearce CL, Chung K, Pike MC, Wu AH ( 2009 ) Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin . Cancer 115 : 531 \u2013 539","journal-title":"Cancer"},{"issue":"Suppl 2","key":"BFbjc2011483_CR20","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/S0021-9681(87)80009-7","volume":"40","author":"MC Pike","year":"1987","unstructured":"Pike MC ( 1987 ) Age-related factors in cancers of the breast, ovary, and endometrium . J Chronic Dis 40 ( Suppl 2 ): S59 \u2013 S69","journal-title":"J Chronic Dis"},{"key":"BFbjc2011483_CR21","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/sj.bjc.6603859","volume":"97","author":"AW Roddam","year":"2007","unstructured":"Roddam AW, Pirie K, Pike MC, Chilvers C, Crossley B, Hermon C, McPherson K, Peto J, Vessey M, Beral V ( 2007 ) Active and passive smoking and the risk of breast cancer in women aged 36\u201345 years: a population based case-control study in the UK . Br J Cancer 97 : 434 \u2013 439","journal-title":"Br J Cancer"},{"key":"BFbjc2011483_CR22","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/humrep\/12.9.1851","volume":"12","author":"JJ Schlesselman","year":"1997","unstructured":"Schlesselman JJ ( 1997 ) Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner\u2019s guide to meta-analysis . Hum Reprod 12 : 1851 \u2013 1863","journal-title":"Hum Reprod"},{"key":"BFbjc2011483_CR23","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0140-6736(03)12949-2","volume":"361","author":"JS Smith","year":"2003","unstructured":"Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V ( 2003 ) Cervical cancer and use of hormonal contraceptives: a systematic review . Lancet 361 : 1159 \u2013 1167","journal-title":"Lancet"},{"key":"BFbjc2011483_CR24","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00228-007-0320-6","volume":"63","author":"J Watson","year":"2007","unstructured":"Watson J, Wise L, Green J ( 2007 ) Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005 . Eur J Clin Pharmacol 63 : 843 \u2013 849","journal-title":"Eur J Clin Pharmacol"},{"key":"BFbjc2011483_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"Writing Group for the Women's Health Initiative Investigators","year":"2002","unstructured":"Writing Group for the Women's Health Initiative Investigators ( 2002 ) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial . JAMA 288 : 321 \u2013 333","journal-title":"JAMA"},{"key":"BFbjc2011483_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.ygyno.2007.12.003","volume":"108","author":"B Zhou","year":"2008","unstructured":"Zhou B, Sun Q, Cong R, Gu H, Tang N, Yang L, Wang B ( 2008 ) Hormone replacement therapy and ovarian cancer risk: a meta-analysis . Gynecol Oncol 108 : 641 \u2013 651","journal-title":"Gynecol Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2011483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011483","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2011483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T15:02:47Z","timestamp":1713193367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2011483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":26,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFbjc2011483"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2011.483","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}